Reaction
Intercepted Product Selection Error reporting signals
As of the last recalculation, Intercepted Product Selection Error appears in 1,240 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is TIRZEPATIDE (PRR 102.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tirzepatide | 553 | 102.9 | 103.2 |
| Insulin Lispro | 273 | 42.2 | 42.3 |
| Insulin Human | 61 | 27.0 | 27.1 |
| Human Insulin | 9 | 12.2 | 12.2 |
| Galcanezumab-Gnlm | 16 | 8.6 | 8.6 |
| Leuprolide Acetate | 30 | 6.6 | 6.6 |
| Dulaglutide | 24 | 4.6 | 4.6 |
| Somatropin | 15 | 3.5 | 3.5 |